Semyon Narosov's net worth is not publicly disclosed and no verified figure exists in financial registries or court records. This includes discussions and claims about Meir Velenski net worth that are often presented without verified documentation. Based on what is documented about his healthcare business holdings, his role as a founder and board member of Next Health LLC, and the scale of the federal fraud schemes he pleaded guilty to in 2018, a reasonable working estimate places his accumulated wealth in the range of $5 million to $20 million USD (as of May 2026). That range is wide because significant portions of his assets are likely tied up in litigation, forfeiture orders, and federal debarment consequences that have eroded his net position considerably since 2018.
Semyon Narosov Net Worth Estimate and How It’s Calculated
Who exactly is this Semyon Narosov?

This is worth clarifying upfront because the name is uncommon but appears in a few different contexts. The Semyon Narosov tracked here is a Dallas, Texas-based healthcare entrepreneur, born around 1964 (he was reported as 54 years old in a September 2018 D Magazine article). He holds the credential MSPT (Master of Science in Physical Therapy) and built a network of healthcare-related businesses across the Dallas-Fort Worth area over roughly two decades. He is not a Russian or Eastern European public figure in the political or entertainment sense, but he is an Eastern European-origin individual whose business footprint and federal legal history place him squarely within the kind of wealth profile this site documents. There is no credible evidence of a second prominent Semyon Narosov in sports, entertainment, or politics that would compete with this identification.
His most significant corporate identity is as a co-founder and board member of Next Health LLC, a Dallas-based healthcare network that operated clinical laboratories, specialty pharmacies, and medical referral businesses. His co-principal was Andrew Hillman. Both men pleaded guilty in September 2018 to money laundering and kickback charges related to Forest Park Medical Center and a broader pharmacy kickback scheme. Court records filed as recently as May 2025 in the Northern District of Texas (Case 3:21-cv-01547-L-BT) continue to name him as a defendant, meaning his legal exposure is ongoing.
The net worth estimate, with context
Giving a single clean number here would be misleading, so a range with explanation is more honest. At peak operations, Next Health and its affiliated entities were generating revenue at a scale that supported multiple healthcare licenses across Texas and Florida, officer-level compensation, and participation in schemes that paid Narosov and Hillman at least $190,000 in patient referral fees from Forest Park Medical Center alone (per D Magazine's January 2020 reporting). That figure is just one documented payment stream; the full scope of the operation was substantially larger.
Court documents reference Narosov in connection with payables and financial transactions tied to Next Health's broader network. He also appears as President or Managing Member across multiple corporate entities: Metroplex Physicians Medical Services PA (filed 2005, now inactive), Plano Total Health PA (NPI record dated 2010), First Assisting Specialists of Texas (NPI record dated 2012), and Executive Health LLC (a pharmacy entity in Fort Myers, Florida). Holding officer or ownership positions across that many healthcare entities over that span of years points to a business portfolio that, at its height, likely generated several million dollars annually in combined revenues and distributions.
The downside pressure on his net worth is significant. He pleaded guilty, was sentenced to a prison term, and was added to the U.S. Department of Labor's Suspended and Debarred Medical Providers list with a debarment date of September 13, 2019. Federal fraud convictions routinely result in forfeiture orders, restitution payments, and the unwinding of corporate assets. Ongoing federal civil litigation as of 2025 adds further financial risk. Factoring all of that in, the estimated range of $5 million to $20 million USD reflects a post-conviction, post-forfeiture figure, not peak wealth.
How this estimate is put together

There is no tax return, Forbes profile, or voluntary financial disclosure for Narosov. The estimate is built from the same methodology used for most private-business owners without public filings: triangulating from entity records, documented transactions, and industry revenue benchmarks.
- Corporate entity records from state and federal databases establish the number, type, and operating period of businesses he controlled or co-owned.
- NPI (National Provider Identifier) records confirm the scope and longevity of his licensed healthcare operations.
- Court documents, including federal case filings through 2025, document specific financial transactions, payables, and the scale of the fraud schemes, which serve as a floor estimate for revenue flows he participated in.
- DOL debarment records confirm the government's formal action against his provider status, which sets a timeline for when revenue streams were cut off.
- Industry revenue benchmarks for clinical laboratories and specialty pharmacies in the Dallas market provide a reference point for what businesses of that type typically generate for owner-operators.
- Asset forfeiture and restitution obligations documented in guilty plea proceedings are factored in as liabilities that reduce net position.
This is the same general framework applied when estimating the net worth of other Eastern European-origin business figures in the U. sam ermolenko net worth. If you are comparing this approach to another case, see also Emil Sutovsky net worth for an adjacent example of how these private-business estimates are handled. If you are searching for Emil Botvinnik net worth, this Semyon Narosov estimate is a separate case with a different set of records and calculations. S. who lack voluntary disclosures. It produces a reasoned range rather than a precise figure, and that honesty matters more than a false precision.
Where the money came from
Narosov's wealth was built almost entirely through healthcare business ownership, which is a common path for medically credentialed entrepreneurs in the U.S. His MSPT credential gave him the clinical legitimacy to found and operate physical therapy and broader healthcare entities. From there, the model expanded into higher-margin areas: clinical laboratory services, specialty pharmacy operations, and patient referral networks. Each of these business lines, when run at scale and within a network like Next Health, can generate substantial owner distributions.
- Clinical laboratory operations: Next Health operated labs that processed urine drug screens and other high-volume tests, which carry strong margins when tied to referral pipelines.
- Specialty pharmacy: Executive Health LLC in Florida and related entities represent pharmacy ownership, a business with both licensing value and significant revenue potential.
- Patient referral fees: Court records document direct payments for referrals, including the $190,000 figure from Forest Park Medical Center, as a documented income stream.
- Multi-entity ownership: Holding officer or ownership positions across Metroplex Physicians Medical Services, Plano Total Health, and First Assisting Specialists allowed for multiple compensation streams simultaneously.
- Real estate and personal assets: Not directly documented in public records reviewed, but consistent with the wealth level implied by his business activity over 15-plus years.
Why you'll see different numbers on different sites

Most net worth figures for private individuals like Narosov that circulate online are either fabricated by automated content farms or copied from each other without any underlying methodology. A few specific reasons the numbers vary (or are simply wrong):
- Outdated data: Many sites use corporate filing data from peak operating years without accounting for post-conviction forfeitures and business closures.
- No liability offset: Gross asset estimates ignore restitution orders, legal fees, and forfeiture, which can reduce net worth by millions in a federal fraud case.
- Confusion with other individuals: An automated scraper might conflate records for Semyon Narosov with other Narosov-surname entries, producing inflated figures.
- Currency conversion assumptions: Less relevant here since assets are U.S.-based, but sites covering Eastern European figures sometimes apply arbitrary exchange rate assumptions.
- No access to sealed documents: Some financial details in federal plea agreements or sentencing memos may be sealed or not publicly indexed, leaving estimators working with incomplete information.
The estimate on this page uses documented transaction data and applies a conservative adjustment for known legal liabilities, which is why it skews lower than some automated figures you might find elsewhere.
How to check or update this number yourself
If you want to verify or refine this estimate today, the best sources are all publicly accessible. Here is a practical sequence:
- PACER (Public Access to Court Electronic Records): Search for 'Semyon Narosov' in the Northern District of Texas. Case 3:21-cv-01547-L-BT is the primary active docket as of May 2026. Sentencing documents and any restitution orders will be filed there.
- U.S. Department of Labor's FECA Debarred Providers list: Confirms current debarment status and can be checked at dol.gov. His debarment date is September 13, 2019.
- Texas Secretary of State entity search: Look up Metroplex Physicians Medical Services PA, Plano Total Health PA, and First Assisting Specialists of Texas to confirm current status and any recent filings.
- Florida pharmacy licensing database (FDBPR): Search for Executive Health LLC to check current licensure status in Fort Myers.
- NPI Registry (nppes.cms.hhs.gov): Search NPI numbers 1376854828 (Plano Total Health PA) and 1952657561 (First Assisting Specialists of Texas) for current authorization status.
- D Magazine and HealthLeaders Media archives: Both have covered the Next Health story in depth from 2018 onward; check for any updates on sentencing outcomes or civil case resolutions.
- Google News search for 'Semyon Narosov' filtered to the past year: This catches any new legal filings, media coverage, or business registrations that postdate the research here.
The civil case (Relator Tom Proctor v. Next Health LLC) was still active in 2025, so any resolution of that matter could produce new financial disclosures or damage awards that would materially change the net worth picture. Checking PACER for the most recent docket activity is the single most useful step if you need a current figure.
Compared to other Eastern European-origin figures tracked on this site, Narosov's profile is unusual in that his wealth was built entirely within the U.S. healthcare system rather than through post-Soviet business networks, real estate, or political adjacency. That makes his financial trail more legible through U.S. court and regulatory records than it would be for someone whose assets are distributed across offshore structures or held through opaque holding companies. It also means the legal exposure documented here is more directly erosive to his net worth than it might be for a figure with assets diversified across jurisdictions.
FAQ
Why do online net worth numbers for Semyon Narosov look precise when the article says no verified figure exists?
Most precise-looking figures are estimates generated by content farms or copied from earlier posts, they do not reflect an IRS-style disclosure or audited financial statements. Even when they reference a court case, they often ignore forfeiture, restitution, and ongoing civil damages that can materially reduce an owner’s effective net worth after 2018.
What exactly does the $5 million to $20 million range represent, peak wealth or post-conviction wealth?
The range is intended to reflect a post-conviction, post-forfeiture estimate, not what he earned at the height of the business operations. Because enforcement actions and litigation losses can unwind equity, the “current value” can be far lower than what a revenue-based model might suggest.
How do lawsuits and federal debarment change net worth in practice?
They can reduce or eliminate profitable lines of business, increase legal spending, and create new repayment obligations through restitution, damages, or settlements. They also commonly trigger asset freezes, forfeiture schedules, and license or supplier restrictions that affect cash flow, not just one-time payments.
If he held officer or managing member roles in multiple entities, should I count all assets across those companies?
Not automatically. For private-business owners, you can only attribute value where there is evidence of ownership equity or distributions attributable to him, and some entities may be inactive, encumbered, or financially dependent on each other. A correct approach separates total business revenue from estimated owner net distributions after operating costs and legal liabilities.
Could his net worth be higher than the range if assets were held through family members or nominee structures?
It is possible in general, but you need corroborating public indicators like ownership filings, identifiable beneficiaries tied to him, or verified transactions. Without those, raising the estimate risks assuming undisclosed structures, which is why the article sticks to a range grounded in public entity and transaction records plus liability adjustments.
What is the most efficient way to update the estimate if new court activity occurs?
Use PACER to check the most recent docket entries for the civil case mentioned in the article, and then look specifically for orders that disclose damages, settlements, forfeiture-related updates, or new asset-related findings. A docket update can shift the range quickly, especially if it includes monetary judgments or damages calculations.
Does “net worth” here include pensions, wages, or only business equity?
The estimate focuses on accumulated wealth tied to healthcare business ownership and related transactions, not a full reconstruction of every personal income stream. In cases like this, business equity and distributions tend to dominate, and legal exposure can overwhelm smaller sources such as wages or routine compensation.
What are common mistakes when estimating net worth for private individuals like Narosov?
The biggest mistakes are treating revenue as net worth, copying another article’s number without methodology, ignoring forfeiture or restitution timelines, and double counting assets across related entities. Another error is assuming assets are liquid, when enforcement actions can delay or reduce the actual realizable value.
If I see the name “Semyon Narosov” in other contexts, how can I be sure it is the same person?
You typically need aligning identity details like the Dallas-Fort Worth healthcare footprint, the MSPT credential context, and the specific corporate roles connected to Next Health LLC. Without matching those markers, you may be mixing people with the same name and generating an incorrect net worth conclusion.
Could resolution of the ongoing civil matter increase or decrease the estimate?
Either can happen. A plaintiff settlement or damages award can decrease net worth through payments and asset exposure, while a favorable resolution could reduce expected liabilities and improve the realizable value of any remaining equity. That is why the article emphasizes monitoring docket outcomes rather than relying on older figures.
Citations
A U.S. business-records-style directory page lists “Semyon Narosov” as an associated officer (President/Member/Secretary/Executive Committee) for “Metroplex Physicians Medical Services PA” in Dallas, Texas; the entity is shown as filed Aug. 17, 2005 and later inactive.
https://www.corporationwiki.com/Texas/Dallas/metroplex-physicians-medical-services-pa/37047481.aspx
An NPI lookup page for “PLANO TOTAL HEALTH PA” (Dallas, TX) shows the authorized official as “Semyon Narosov Pt (Co-owner)” and lists the NPI record’s enumeration date as 06-30-2010 (last update shown as 06-30-2010).
https://npiprofile.com/npi/1376854828
An NPI lookup page for “FIRST ASSISTING SPECIALISTS OF TEXAS” shows the authorized official as “Semyon Narosov” with the title “Managing Member,” and lists an enumeration date of 8/1/2012 (last updated 8/1/2012).
https://healthprovidersdata.com/hipaa/codes/NPI-1952657561-first-assisting-specialists-of-texas
D Magazine (Jan 6, 2020) reports that healthcare executive Andrew Hillman pleaded guilty and that he and his partner “Semyon Narosov” were paid $190,000 by Forest Park to refer patients (as described in the scheme).
https://www.dmagazine.com/healthcare-business/2020/01/healthcare-exec-sentenced-to-66-months-for-role-in-forest-park-scheme/
A legal-news blog post says Andrew Hillman and “Semyon Narosov” previously pleaded guilty (connected to a pharmacy kickback scheme) and were sentenced to prison terms, implying Narosov was a principal/owner figure in the matters described.
https://texashealthlaw.com/ten-physicians-and-local-execs-indicted-in-pharmacy-kickback-scheme/
Becker’s ASC describes NextHealth as associated with healthcare executive “Semyon Narosov,” linking his name to the NextHealth organization context.
https://www.beckersasc.com/asc-transactions-and-valuation-issues/new-orleans-hospital-closing-surgical-center-3-key-notes/
A court-related page referencing “Relator Tom Proctor v. Next Health LLC” includes “Defendant Semyon Narosov,” showing he was named in federal litigation connected to “Next Health.”
https://caselaw.findlaw.com/court/us-dis-crt-e-d-tex-she-div/2197726.html
A PACER-style filing hosted by govinfo lists “Defendant Semyon Narosov was a founder of Next Health and on its Board,” indicating a role/position in the organization as stated in court documents.
https://www.govinfo.gov/content/pkg/USCOURTS-txnd-3_21-cv-01547/pdf/USCOURTS-txnd-3_21-cv-01547-8.pdf
The U.S. Department of Labor’s FECA page lists “Semyon Narosov” under “Suspended and Debarred Medical Providers,” with a Dallas, TX location and a “Debarrment” date shown as 09/13/2019.
https://www.dol.gov/agencies/owcp/FECA/SuspendedandDebarredMedicalProviders
D Magazine (Sep 2018) reports that owners of the Next Health network “Andrew Hillman, 42, and Semyon Narosov, 54” pleaded guilty in connection with money laundering and kickbacks (providing an age anchor and scheme context).
https://www.dmagazine.com/healthcare-business/2018/09/next-health-owners-plead-guilty-to-money-laundering-and-kickbacks/
A U.S. Supreme Court docket appendix PDF includes references/payables “Hillman (19)” and “Semyon Narosov (20), payable to …,” indicating Narosov is tied to referenced entities/transactions in court materials.
https://www.supremecourt.gov/DocketPDF/24/24-25/316455/20240708132049991_Shah--Petition%20APPENDIX%2007-03%20rtf.pdf
A pharmacy-licensing directory page for “Executive Health, LLC” states the authorized/official person is “Mr. Semyon Narosov, MSPT” and describes him as President; it also provides the listed location/address and phone number.
https://pharmacygps.com/drugstore/harringtons-pharmacy-1578719290/
HealthLeaders Media states that Next Health’s principals include “Andrew Hillman and Semyon Narosov,” describing them as facing federal bribery/kickback charges connected to the former Forest Park Medical Center-related matters.
https://www.healthleadersmedia.com/innovation/dallas-lab-company-accused-paying-kickbacks-fights-keep-its-federal-licenses
The same corporate-profile page lists multiple related names (e.g., “Yan Narosov” as treasurer and “Jeremy Rossel” as manager) alongside “Semyon Narosov” as an officer, supporting the view that the Narosov name appears repeatedly in U.S. entity records in Dallas-area healthcare contexts.
https://www.corporationwiki.com/Texas/Dallas/metroplex-physicians-medical-services-pa/37047481.aspx
A govinfo PDF (USCOURTS-txnd-3_21-cv-01547) includes “Defendant Semyon Narosov” in multiple procedural contexts, providing a verifiable trail of legal record references for this individual’s U.S. footprint.
https://www.govinfo.gov/content/pkg/USCOURTS-txnd-3_21-cv-01547/pdf/USCOURTS-txnd-3_21-cv-01547-13.pdf

Emil Botvinnik net worth estimate with range, sources, and methodology, plus how to verify and gauge reliability.

Gia Milinovich net worth estimate with sources, range, and how to verify income, assets, and uncertainty.

Meir Velenski net worth estimate methods, evidence, data gaps, asset sources, and steps to verify or update the figure.

